These OTC Securities Had the Most Trading Activity in July
Photo by Federico Beccari on Unsplash
Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability
Company’s Strong First Half 2021 Viewed as Launch Pad for Accelerating Second Half and Growth Trajectory, Propelled by Multiple Platform Technologies Building Market Traction
Pressure BioSciences Announces Major Business Expansion, Establishing Eco-Friendly Agrochemicals Subsidiary and Initiating Plans to Drive Accretive 2021 Revenue
Significant Order for Environmentally Friendly Agrochemical Material Placed to Fulfill Initial Demand; Subsidiary will House Announced Asset Acquisition from Global Agrochemicals Innovator
New Ultra Shear Technology for Nanoemulsions Will Transform Multiple Large Markets; Latest Breakthrough From Pressure BioSciences
Photo by ThisIsEngineering from Pexels The leading developer of high-pressure-based platform technologies for life sciences applications worldwide, Pressure BioSciences (OTCQB:PBIO) (“PBI”)…
Pressure BioSciences Novel UST™ Platform Delivers Breakthrough Nanoemulsion Processing for One of the World’s Most Potent Antioxidants – Astaxanthin
Unprecedentedly Tiny, Uniform, and Stable Nanoemulsified Oil Droplets Containing Astaxanthin Expected to Significantly Increase Oral and Topical Absorption of this Antioxidant 6,000x More Powerful Than Vitamin C.